First Wave BioPharma News - FWBI

Company Name	Stock Ticker Symbol	Market	Type
First Wave BioPharma Inc	FWBI	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.04	-1.47%	2.69	09:40:36

Open Price	Low Price	High Price	Close Price	Prev Close
2.67	2.55	2.73		2.73

more quote information »

Recent News

Date	Time	Source	Heading
4/24/2024	07:00	GLOBE	First Wave BioPharma Announces Invited Paper for Special..
4/17/2024	07:00	GLOBE	First Wave BioPharma CEO James Sapirstein to Present at the..
4/15/2024	07:00	GLOBE	First Wave BioPharma CEO James Sapirstein to Participate in..
3/18/2024	07:00	GLOBE	First Wave BioPharma Announces Two Abstracts on Celiac..
3/14/2024	06:00	GLOBE	First Wave BioPharma Announces Completion of Business..
3/05/2024	17:26	EDGAR2	Form 8-K - Current report
3/05/2024	07:00	GLOBE	First Wave BioPharma to Participate In ‘Fireside Chat’ at..
3/04/2024	17:29	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/2024	08:00	GLOBE	First Wave BioPharma, Inc. to Raise Approximately $4.0..
2/13/2024	07:00	GLOBE	First Wave BioPharma CEO to Present at the BIO CEO &..
1/23/2024	07:00	GLOBE	First Wave BioPharma to Present at the DealFlow MicroCap..
1/18/2024	16:01	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/18/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/17/2024	16:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	07:00	GLOBE	First Wave BioPharma CEO to Present at the Sequire Investor..
1/08/2024	17:14	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/04/2024	17:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	17:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	08:22	EDGAR2	Form 8-K - Current report
1/04/2024	06:00	GLOBE	First Wave BioPharma Chairman and CEO Issues Letter to..
1/03/2024	19:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/28/2023	12:21	EDGAR2	Form RW - Registration Withdrawal Request
12/27/2023	17:23	EDGAR2	Form 8-K - Current report
12/27/2023	11:55	GLOBE	First Wave BioPharma Announces Exercise of Warrants and..
12/27/2023	08:04	EDGAR2	Form S-1/A - General form for registration of securities..
12/27/2023	06:15	EDGAR2	Form 8-K - Current report
12/27/2023	06:00	GLOBE	First Wave BioPharma Announces Streamlining of Clinical..
12/18/2023	07:00	EDGAR2	Form 8-K - Current report
12/18/2023	06:00	GLOBE	First Wave BioPharma Announces Entry into Term Sheet for..
12/15/2023	21:48	EDGAR2	Form S-1/A - General form for registration of securities..
12/14/2023	09:15	EDGAR2	Form 8-K - Current report
12/14/2023	09:15	GLOBE	First Wave BioPharma Announces 1-for-20 Reverse Stock Split..
12/06/2023	07:00	GLOBE	First Wave BioPharma to Participate in BIO Partnering @JPM..
12/05/2023	07:00	GLOBE	First Wave BioPharma CEO James Sapirstein to Moderate Panel..
11/13/2023	16:20	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/13/2023	16:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/2023	16:51	EDGAR2	Form S-1 - General form for registration of securities under..
10/31/2023	17:24	EDGAR2	Form PRER14A - Preliminary Proxy Soliciting materials
10/31/2023	17:21	EDGAR2	Form 8-K - Current report
10/12/2023	17:06	EDGAR2	Form PRE 14A - Other preliminary proxy statements
10/10/2023	16:06	EDGAR2	Form 8-K/A - Current report: [Amend]
10/10/2023	07:00	GLOBE	Date and Time Announced for First Wave BioPharma CEO James..
10/06/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	07:00	GLOBE	First Wave BioPharma CEO James Sapirstein to Present at the..
10/02/2023	09:20	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/22/2023	09:38	EDGAR2	Form S-3 - Registration statement under Securities Act of..
9/15/2023	16:05	EDGAR2	Form 8-K - Current report
9/15/2023	08:45	GLOBE	First Wave BioPharma To Present at the BIO Investor Forum
9/14/2023	10:43	GLOBE	First Wave BioPharma Announces Exercise of Warrants and..
9/14/2023	06:19	EDGAR2	Form 8-K - Current report